Literature DB >> 27313801

Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects.

Wan-Qin Xie1, Lin Zhou1, Yong Chen1, Bin Ni1.   

Abstract

BACKGROUND: MicroRNAs are small non-coding RNAs of approximately 22 nucleotides in length, and play important regulatory roles in normal heart development and the pathogenesis of heart diseases. Recently, a few prospective studies have implicated the diagnostic role of microRNAs in congenital heart defects (CHD). DATA RESOURCES: This review retrieved the research articles in PubMed focusing on the altered microRNAs in cardiac tissue or serum of patients with CHD versus healthy normal controls, as well as the studies exploring circulating microRNAs as potential biomarkers for (fetal) CHD.
RESULTS: Most of the studies of interest were conducted in recent years, implicating that the topic in this review is a newly emerging field and is drawing much attention. Moreover, a number of differentially expressed microRNAs between CHD specimens and normal controls have been reported.
CONCLUSION: Circulating microRNAs may serve as potential biomarkers for diagnosis of CHD in the future, with more efforts paving the road to the aim.

Entities:  

Keywords:  Biomarkers; Congenital heart defects; MicroRNA

Year:  2016        PMID: 27313801      PMCID: PMC4905874          DOI: 10.5847/wjem.j.1920-8642.2016.02.001

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  33 in total

1.  Prenatal diagnosis of congenital heart defects: accuracy and discrepancies in a multicenter cohort.

Authors:  C L van Velzen; S A Clur; M E B Rijlaarsdam; E Pajkrt; C J Bax; J Hruda; C J M de Groot; N A Blom; M C Haak
Journal:  Ultrasound Obstet Gynecol       Date:  2016-05       Impact factor: 7.299

Review 2.  Current State of Circulating MicroRNAs as Cancer Biomarkers.

Authors:  Yuqing He; Juanjuan Lin; Danli Kong; Mingyuan Huang; Chengkai Xu; Taek-Kyun Kim; Alton Etheridge; Yanhong Luo; Yuanlin Ding; Kai Wang
Journal:  Clin Chem       Date:  2015-08-03       Impact factor: 8.327

Review 3.  Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.

Authors:  Thomas Thum; Gianluigi Condorelli
Journal:  Circ Res       Date:  2015-02-13       Impact factor: 17.367

4.  Congenital heart disease: entering a new era of human genetics.

Authors:  Benoit G Bruneau; Deepak Srivastava
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

5.  Roles of miR-1-1 and miR-181c in ventricular septal defects.

Authors:  Jian Li; Yinyin Cao; Xiao-jing Ma; Hui-jun Wang; Jin Zhang; Xin Luo; Weicheng Chen; Yao Wu; Yingying Meng; Jing Zhang; Yuan Yuan; Duan Ma; Guo-ying Huang
Journal:  Int J Cardiol       Date:  2013-01-24       Impact factor: 4.164

6.  Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4.

Authors:  M W Schilham; M A Oosterwegel; P Moerer; J Ya; P A de Boer; M van de Wetering; S Verbeek; W H Lamers; A M Kruisbeek; A Cumano; H Clevers
Journal:  Nature       Date:  1996-04-25       Impact factor: 49.962

Review 7.  Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.

Authors:  Altaf A Kondkar; Khaled K Abu-Amero
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 8.  Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.

Authors:  Meng Li; Junping Zhang
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

9.  Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries.

Authors:  Clare T M Lai; Enders K O Ng; Pak-cheong Chow; Ava Kwong; Yiu-fai Cheung
Journal:  BMC Cardiovasc Disord       Date:  2013-09-16       Impact factor: 2.298

10.  Characterization of circulating microRNA expression in patients with a ventricular septal defect.

Authors:  Dong Li; Long Ji; Lianbo Liu; Yizhi Liu; Haifeng Hou; Kunkun Yu; Qiang Sun; Zhongtang Zhao
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

View more
  7 in total

1.  Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study.

Authors:  Clint Gray; Lesley M McCowan; Rachna Patel; Rennae S Taylor; Mark H Vickers
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

2.  Experience with genomic sequencing in pediatric patients with congenital cardiac defects in a large community hospital.

Authors:  Natalie S Hauser; Benjamin D Solomon; Thierry Vilboux; Alina Khromykh; Rajiv Baveja; Dale L Bodian
Journal:  Mol Genet Genomic Med       Date:  2018-01-25       Impact factor: 2.183

Review 3.  Epigenetics and Mechanobiology in Heart Development and Congenital Heart Disease.

Authors:  Dillon K Jarrell; Mallory L Lennon; Jeffrey G Jacot
Journal:  Diseases       Date:  2019-09-01

Review 4.  The role of DNA methylation in syndromic and non-syndromic congenital heart disease.

Authors:  Jiali Cao; Qichang Wu; Yanru Huang; Lingye Wang; Zhiying Su; Huiming Ye
Journal:  Clin Epigenetics       Date:  2021-04-26       Impact factor: 6.551

5.  Altered microRNA and target gene expression related to Tetralogy of Fallot.

Authors:  Marcel Grunert; Sandra Appelt; Ilona Dunkel; Felix Berger; Silke R Sperling
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

Review 6.  Clinical application of exosomes and circulating microRNAs in the diagnosis of pregnancy complications and foetal abnormalities.

Authors:  Haiou Yang; Qianqian Ma; Yu Wang; Zhenhua Tang
Journal:  J Transl Med       Date:  2020-01-22       Impact factor: 5.531

7.  Association analysis of maternal MTHFR gene polymorphisms and the occurrence of congenital heart disease in offspring.

Authors:  Mengting Sun; Tingting Wang; Peng Huang; Jingyi Diao; Senmao Zhang; Jinqi Li; Liu Luo; Yihuan Li; Letao Chen; Yiping Liu; Jianhui Wei; Xinli Song; Xiaoqi Sheng; Jiabi Qin
Journal:  BMC Cardiovasc Disord       Date:  2021-06-14       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.